Pediatric HIV infection remains a global health crisis with a worldwide infection rate of 2.5 million (WHO, Geneva Switzerland, 2009). Children are much more susceptible to HIV-1 neurological impairments compared with adults, which is exacerbated by coinfections. A major obstacle in pediatric HIV research is sample access. The proposed studies take advantage of ongoing pediatric simian immunodeficiency virus (SIV) pathogenesis and vaccine studies to test the hypothesis that pediatric SIV infection diminishes neuronal populations and neurogenesis in the hippocampus. Newborn rhesus macaques (Macaca mulatta) that received intravenous inoculation of highly virulent SIVmac251 (n = 3) or vehicle (control n = 4) were used in this study. After a 6-18-week survival time, the animals were euthanized and the brains prepared for quantitative histopathological analysis. Systematic sections through the hippocampus were either Nissl stained or immunostained for doublecortin (DCX +), a putative marker of immature neurons. Using design-based stereology, we report a 42% reduction in the pyramidal neuron population of the CA1, CA2, and CA3 fields of the hippocampus (P < 0.05) in SIV-infected infants. The DCX + neuronal population was also significantly reduced within the dentate gyrus of the hippocampus. The loss of hippocampal neurons and neurogenic capacity may contribute to the rapid neurocognitive decline associated with pediatric HIV infection. These data suggest that pediatric SIV infection, which leads to significant neuronal loss in the hippocampus within 3 months, closely models a subset of pediatric HIV infections with rapid progression. 
Introduction
An estimated 1500 children under the age of 15 years become infected with HIV-1 daily in resource-poor areas, with most being perinatally infected through mother-tochild-transmission (MTCT) [1] . Although B100 countries have implemented prevention of mother-to-child transmission (PMTCT) of HIV, only an estimated 10% of pregnant women are offered this service worldwide and less than 6% in resource-poor areas. Perinatal transmission rates in developing nations remain high despite the efforts of UNAIDS to eliminate new HIV infections among children by 2015 [1] . Within the USA, there is a perinatal infection rate of 1-3% annually despite early identification and triple antiretroviral therapy (ART). The developing immune system is more susceptible than that of an adult to adverse viral infections [2] , with about 25% of HIV-infected infants dying before their second birthday [3] .
Infants are disproportionately affected by HIV-1-related neurological impairments in comparison with adults [4, 5] with children often showing neurobehavioral deficits before significant immunosuppression [6] . Imaging studies on HIV-1-positive children have shown gross brain disturbances resulting in ventrical enlargement, sulcal widening, white matter lesions, encephalopathy, global cortical atrophy, basal ganglia calcifications, altered metabolite concentrations in the frontal cortex and hippocampus, and potential demylenation of the corpus callosum [6] [7] [8] . Neurobehavioral deficits suggest dysfunction of the frontal cortex, as well as the hippocampus, with affected children presenting a range of fine and gross motor impairments, cognitive delays, verbal deficits, memory deficits, visual impairment, abnormal muscle tone, and spasticity [4, 6, 7] .
Neonatal rodent models of intracranial HIV-1 tat antigen administration further support clinical evidence that the neurons of the hippocampus, as well as hippocampal neurogenesis, are particularly susceptible to the neurotoxic cascade of HIV-1 proteins [9] . Scarce pathology reports on HIV-infected children have provided evidence of apoptosis in the cerebral cortex associated with perivascular inflammation [10] , but have been limited in addressing HIV-induced neuropathogenesis. Because of the persistent rates of HIV-1 infection in developing nations [2] [3] [4] , an assessment of the impact of early HIV-1 infection on brain development is urgently needed. A significant barrier to pediatric HIV-1 neurological research is sample access [2] .
Nonhuman primates such as infant macaques offer a valid alternative because they show similar neuroanatomical and immune system development to human infants [2] . Further, HIV and simian immunodeficiency virus (SIV) infections share a similar pathophysiology and MTCT is replicable in monkeys [2] . The pathogenic uncloned SIVmac251 isolate used in the current study closely models a subset of pediatric HIV infection with persistently high virus replication and rapid progression; infant macaques progress to simian AIDS within 6 months. In light of the clinical manifestations of pediatric HIV infection and the effects of HIV-related proteins on the developing rodent brain, we tested the hypothesis that SIV infection deleteriously affects the integrity of the hippocampus by reducing the pyramidal and immature neuronal populations in a pediatric model of HIV infection.
Methods
Newborn rhesus macaques (Macaca mulatta) were handreared in the nursery of the California National Primate Research Center (CNPRC) in accordance with American Association for Accreditation of Laboratory Animal Care standards. We strictly adhered to the 'Guide for the Care and Use of Laboratory Animals' prepared by the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Resources, National Resource Council. The experimental protocol was reviewed and approved by the University of California Davis Institutional Animal Care and Use Committee. A total of seven neonatal monkeys were randomly assigned to one of two groups (group 1 -control, n = 4; group 2 -SIV infection, n = 3). Within 72 h after birth, subjects in group 2 received intravenous inoculation with 100 tissue culture doses 50% (TCID 50 ) of SIVmac251 obtained from the Analytical and Resource Core at CNPRC [2] . Plasma viral loads were quantified by real-time reverse transcriptase-PCR [11] . Although the dose of this viral inoculum is still higher than that at which most human infants acquire perinatal HIV infection, this moderate dose was selected to obtain a 100% infection rate in a wellestablished animal model of perinatal infection [2] ( Table 1) .
The SIV-infected infants were euthanized between 7 and 10 weeks of age (Table 1) when they met the established clinical criteria for euthanasia of retrovirus-infected animals (including symptoms like lethargy, weight loss, dehydration, diarrhea, and opportunistic infections unresponsive to standard treatments). The brains were extracted, postfixed in 10% formalin, blocked into 1-cm slabs in the coronal plane, cryoprotected in 30% buffered sucrose, and frozen at -801C until further processing. Ten parallel series of coronal sections (50 mm) were obtained from each animal with the first series being Nissl stained with cresyl-violet for design-based stereological analysis. The remaining series were placed in antigen preserve (50% ethylene glycol, PBS pH = 7.4, and 1% polyvinylpyrrolidone) and stored at -201C for future immunohistochemical analysis.
Design-based stereological analysis
Total estimation of the pyramidal neuronal population of the hippocampal cornu ammonis fields (CA1-3) was achieved using the optical fractionator method. Sampling parameters are similar to those in the previously described methods of design-based stereological analysis in the primate hippocampus [13] . Briefly, section topography and superimposed counting frames (disectors) were generated using the MicroBrightField StereoInvestigator program (MicroBrightField Inc., Williston, Vermont, USA) on a Nikon Eclipse microscope under Â 4 (topography) and Â 60 (counting objective: Plan Fluor oil-immersion, NA = 1.4) objectives. For the stereological parameters in this study, every 20th section was selected with a random starting point within 500 mm of the beginning of the CA fields and continued until the CA fields were no longer visible. Sampling in the absence of a visible dentate gyrus granular layer of the most anterior and posterior regions ensured an estimation of the entire CA hippocampal neuronal population. The total number (N) of pyramidal neurons was calculated using the following equation:
where SSF is the section-sampling fraction, ASF is the area-sampling fraction, TSF is the thickness-sampling fraction (the measured thickness of the tissue divided by the dissector height), and SQis the number of objects of interest counted. For this study, a neuron was defined as having a visible centrally located nucleolus and a defined cytoplasm. The average coefficient of error (CE) Specific gravity was determined by dividing brain weight (g) by water displacement (ml). The anterior-posterior measurements were taken using a caliper, and the plasma viral load was determined by real-time RT-PCR. The hippocampal pyramidal neuronal population remains steady over the course of the first 2 years of life [12] . Therefore, reductions in the pyramidal neuronal population are likely to reflect the effects of SIV infection as opposed to age-related differences. RT, reverse transcriptase; SIV, simian immunodeficiency virus.
for the total number of neurons was determined to assess the reliability of measurements.
Immunohistochemistry
A complete series of sections spanning the entire hippocampal area was taken from the developmental brain bank for doublecortin staining (DCX), a putative marker of immature neurons [14] . Standard batch immunohistochemical techniques were followed for the DCX immunohistochemical analysis. Briefly, free-floating sections were rinsed in PBS three times, incubated for 1 h in a pretreatment buffer (3% hydrogen peroxide, 20% methanol in PBS), blocked for 1 h in 3% normal horse serum, and then incubated overnight with goat anti-DCX antibodies (1 : 400, #sc-8066; Santa Cruz Biotechnology, Dallas, Texas, USA) at room temperature. The next day, the sections were washed in PBS and incubated with horse anti-goat secondary antibodies (1 : 200; Vector) for 1.5 h, followed by 1.5 h of incubation with ABC (Vector Laboratories Inc., Burlingame, California, USA); they were then visualized with diaminobenzidine (Sigma-Aldrich, St Louis, Missouri, USA). Thereafter, sections were wetmounted on gelatinized slides and air dried overnight. The following day, the sections were dehydrated in graded ethanol (50-100%), cleared in xylene, and coverslipped with DPX mounting media (VWR Int., Poole, UK).
Statistical analysis
Statistical differences were determined using the Mann-Whitney U-test of significance on the GraphPad InStat3 program (La Jolla, California, USA). The coefficient of variation (CV = SD/mean), presented in parentheses, was calculated for neuronal numbers and volume estimation. The CE for the different measurements was calculated as ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi meanCE 2 p .
Results
Every 20th section (SSF) was selected from the entire rostral-caudal extent of the hippocampus. The first sections were taken from the CA1 subfield, which produced a set sample of 13-16 sections throughout the rostral-caudal region. Standard scan grid sizes of 500 Â 500, 250 Â 250, and 350 Â 350 mm were used for CA1, CA2, and CA3, respectively. For each disector site, a standard 40 Â 40 Â 10-mm counting frame was used. Section thickness was measured at each counting site, with an average measured thickness of 17.87 mm, which provided an average guard height of 3.93 mm ( Table 2) .
Perinatal SIV infection resulted in an overall average reduction of 42% (Fig. 1) in the total number of pyramidal neurons (P = 0.0286). There were significant neuronal reductions in the CA1 region (1.106 Â 10 6 , CV=0.05 SIV + vs. 1.996 Â 10 6 , CV = 0.145 control), CA2 region (0.240 Â 10 6 , CV = 0.173 SIV + vs. 0.434 Â 10 6 , CV = 0.057 control), and CA3 region (0.730 Â 10 6 , CV=0.189 SIV+ vs. 1.182 Â 10 6 , CV = 0.174 control) in SIV + versus control subjects (P = 0.0286 for each group; Fig. 1 ). The estimation of neurons produced a BCV 2 /CV 2 ratio of greater than 0.85 for both groups, indicating a low sampling error and a precise estimate of the hippocampal neuronal population (Fig. 2) .
Immunostaining of the hippocampus with DCX indicated an observable reduction in immature neurons in the dentate gyrus. The reduction of DCX + neurons was apparent in each SIV + subject, whereas in the control subjects, the density of immature neurons occluded visible identification of individual neurons (Fig. 2 ).
Discussion
Using a perinatal MTCT nonhuman primate model to study the neuropathogenesis of SIV infection, we provide evidence of loss of pyramidal neurons in the CA1-3 fields, along with a marked reduction in immature neurons, within the first 3 months of infection. Although much of the clinical research focuses on global cortical changes and the basal ganglia [6] [7] [8] , there is increasing evidence of HIV-1-related toxicity in the hippocampus [9, [15] [16] [17] [18] . Neural atrophy of the hippocampus is also reported in young adult monkeys following SIV infection [19] . Intracranial injections of the HIV-1-associated proteins gp120 and Tat in neonatal rats have been found to significantly reduce neuronal populations in the CA2 and CA3 fields of the hippocampus [9, 20] and to suppress The average CE for the number of neurons for all three regions of the hippocampus were <0.073 for CA1, <0.078 for CA2, and <0.064 for CA3, indicating an acceptable variation for this sampling scheme. There was a significant volume reduction restricted to CA1 (P = 0.0286). The estimation of neurons produced a BCV 2 /CV 2 ratio of greater than 0.85 for both groups, indicating a low sampling error and a precise estimate of the hippocampal neuronal population. P F is the average number of dissectors imaged per subject and mean P Qis the average number of neurons counted for each subject. CA, cornu ammonis; CE, coefficient of error; SIV, simian immunodeficiency virus; V ref , reference volume. *P = 0.0286 SIV versus control.
long-term potentiation of CA1 neurons [20] , which was correlated with a decline in spatial memory [9] . In addition, HIV-1 gene sequences have been detected in the hippocampus of postmortem brains [17] .
The paucity of hippocampal neurons following neonatal SIV infection provides anatomical evidence for memory impairments in HIV-infected children. Under normal developmental conditions the pyramidal neuronal population remains stable during the first 2 years of life, whereas neurogenesis in the dentate gyrus peaks during the first 3 months [13] . Thus, any damage to the hippocampal structure/function will likely result in long-term neurological consequences as reported in HIV-positive children [18] . The prevalence of HIV-1 has been reported in neural progenitors of archival pediatric brain tissue, providing clinical evidence for an interaction between HIV-1 and neural progenitors [16] . In vitro, both gp120 and Tat proteins have been found to attenuate proliferation of human neural progenitor cells [18] without affecting the viability of pre-existing human neural progenitor cells [18] . A novel finding in this study is the apparent reduction in DCX + neurons in the dentate gyrus. Whether this reflects a neurotoxic effect on established immature neurons, an acceleration of the maturation process as a repair mechanism, or an attenuation of neural progenitor proliferation remains to be determined.
Neuroinflammation and breakdown of the blood-brain barrier have been implicated as mechanisms contributing to HIV-1-related neurological disorders [21] [22] [23] [24] . Once the virus transverses the blood-brain barrier, its ability to infect cells depends on the presence of CCR5 and CXCR4, which increase in expression from birth until 9 months of age in the primate hippocampus [25] . Expression of CD4 receptors and the chemokine coreceptors CCR5 and CXCR4 plays an important role in the pathogenesis of HIV [25] , and signaling through these receptors results in a balance between survival and proinflammatory neuronal death [26] . These receptors are expressed on neural progenitor cells and have been proposed to play a role in HIV-induced reductions in neurogenesis [24, 27] .
Conclusion
The extent of HIV-1 infection in specific cell types, the extent of neuronal loss, and the mechanism of action of HIV-1 in infants is currently unknown [6] , severely limiting the ability to develop and evaluate therapeutic paradigms to minimize the neurological impairments resulting from HIV-1 infection. Proliferating neural progenitor cells in the dentate gyrus can be upregulated by the serotonin-specific reuptake inhibitor paroxetine even in the presence of HIV Tat protein [18] . Neurobehavioral and cognitive dysfunction remains prevalent in perinatally infected children even if they receive combination ART [4, 6, 8] . Although ART suppresses peripheral viral replication, it has a relatively low bioavailability in the central nervous system, thereby allowing the brain to be a viral reservoir and potentially exacerbating neuropathogenesis of pediatric HIV infection [6] . To take advantage of developmental plasticity in future potential therapeutic interventions aimed at minimizing neurological impairment by pediatric HIV infection, as well as coinfections (e.g. tuberculosis and malaria), it is necessary to define the response to HIV-1 infection during the early developmental period.
